Emerson’s next-generation software directs pharmaceutical development, accelerates time to market

DeltaV Workflow Management delivers scalable recipe creation and execution technologies for life science companies

ST. LOUIS, April 16, 2024 /PRNewswire/ — Global automation technology and software leader Emerson (NYSE: EMR) today introduced DeltaV™ Workflow Management, next-generation software designed for early-stage life science companies. The new software continues Emerson’s expansion of the capabilities of the DeltaV automation platform, which is evolving to offer more scalable options to fit the needs of smaller life science innovators. For companies with limited IT infrastructure, DeltaV Workflow Management provides a cloud-based software-as-a-service solution for easy recipe creation, execution and electronic data collection.

In high-growth life science companies, such as those that make medical products for advanced therapies for hard-to-treat diseases and personalized medicine, manufacturing facilities still rely heavily on manual processes and record-keeping for bench-top operations and original recipes. Many do not have robust IT departments, nor staff with experience in the complex coding required for traditional production systems.

DeltaV Workflow Management removes this layer of complexity by moving prescription flow data from manual records to digital “paper on glass,” providing a simple and scalable solution that helps accelerate the drug development process without the need for coding experience. The software also generates searchable digital records that are easily organized and exported, and data that can be more easily analyzed and reported. In addition, this digital shift reduces contamination risks associated with paper records in sterile cleanrooms.

“DeltaV Workflow Management enables innovation for both startups and established labs that demand speed and simplicity in early stage drug development,” he said Nathan Pettus, president of Emerson’s process systems and solutions business. “Creating and fully automating prescriptions that rely on standard, end-to-end manufacturing systems can take years of experience and months. With this new software, the timeline has been reduced to days, giving companies the advantage of commercializing and getting new therapeutics into the pipeline faster.” “

Within DeltaV Workflow Management, users use simple drag-and-drop elements to create recipe steps and automate workflows that meet Good Manufacturing Practice standards. Within these steps, they can add new parameters and e-signature requirements for quality control and regulatory compliance, trigger product recipes, authorize users for specific tasks, and create digital batch records.

DeltaV Workflow Management extends and complements the user options for developing and executing digital recipes already offered by Emerson’s DeltaV MES—the latest evolution of Syncade MES. Customers now have the added flexibility to align digital recipe solutions with their business needs, underscoring Emerson’s commitment to continuous improvement and investment in a portfolio of manufacturing execution solutions for organizations of any scale.

About Emerson
Emerson (NYSE: EMR) is a global technology and software company that provides innovative solutions for the world’s key industries. Through its leading automation portfolio, including its majority stake in AspenTech, Emerson helps manufacturers of hybrid, process and discrete devices optimize operations, protect personnel, reduce emissions and achieve their sustainability goals. For more information, visit Emerson.com.

SOURCE Emerson

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *